Get the Daily Brief
Latest Biotech News
23andMe Acquired by Founder’s Nonprofit After Bidding War
Anne Wojcicki, co-founder and former CEO of 23andMe, led a nonprofit, the TTAM Research Institute, which has secured a $305 million deal to acquire the majority of 23andMe’s assets after...
Novo Nordisk to Initiate Phase 3 Trials for Next-Generation Obesity Drug Amycretin
Novo Nordisk has announced plans to commence late-stage (phase 3) clinical trials for amycretin, a dual GLP-1 and amylin receptor agonist designed for weight loss. This program includes both...
Rapid Construction of Vascular Organoids via Dual Transcription Factor Activation
Researchers from Boston Children’s Hospital and collaborators have developed an accelerated method to generate vascular organoids from human induced pluripotent stem cells (iPSCs) by...
Advanced Multiomics Partnerships Accelerate Biological Insight
Multiomics approaches integrating genomics, transcriptomics, and proteomics are increasingly central to life sciences. Ultima Genomics and partners like Olink Proteomics have collaborated to...
New Cooling Technology Promises Energy Savings for Data Centers
Engineers at the University of California San Diego have developed an evaporative cooling technology using fiber membranes with controlled porosity to passively dissipate heat from electronics....
AI Trained on Single-Cell Immune Data to Enhance Cancer Immunotherapy
Immunai has partnered with the Parker Institute for Cancer Immunotherapy to generate a large-scale, clinically annotated single-cell gene expression dataset from over 1,000 cancer patients...
AI Advances Psychiatry with Faster, Smarter Treatment Decisions
Clinical trials and real-world data increasingly harness artificial intelligence and digital biomarkers to refine psychiatric treatment strategies. AI tools offer psychiatrists improved...
FDA Approves Pembrolizumab for Resectable Head and Neck Cancer
The FDA approved pembrolizumab for resectable locally advanced head and neck cancer with PD-L1 expression, based on data from the KEYNOTE-689 phase 3 trial showing improved event-free survival and...
J&J’s Dual-Target CAR-T Shows 100% Response in Phase 1b Trial
Johnson and Johnson reported a 100% objective response rate in relapsed/refractory large B-cell lymphoma patients with one prior therapy using its dual CD19/CD20-targeting CAR-T. The therapy...
ADC Therapeutics Shuts UK Site, Cuts 30% Workforce After Pipeline Losses
After discontinuing its only clinical-stage candidate, ADC Therapeutics announced closure of its UK R&D facility and a 30% staff reduction. Several early programs were halted to focus resources on...
FDA Approval Shifts Head and Neck Cancer Care Paradigm
The FDA has approved pembrolizumab for patients with resectable locally advanced head and neck squamous cell carcinoma expressing PD-L1, marking the first checkpoint inhibitor approval in the...
Pivotal Clinical Data in Dual-Targeting CAR-T Cell Therapy for Lymphoma
Johnson and Johnson released encouraging phase 1b data for their dual-targeting CD19/CD20 CAR-T therapy in relapsed or refractory large B-cell lymphoma patients. The objective response rate was...
Financial Surge Follows Positive Hypertension Readout at Insmed
Insmed mailed a $750 million follow-on public equity offering following positive clinical data in hypertension. The financing round highlights growing investor confidence fueled by clinical...
Nonprofit Led by Anne Wojcicki Secures 23andMe Asset Acquisition
Former CEO Anne Wojcicki’s nonprofit, the TTAM Research Institute, won a second auction to acquire 23andMe’s assets for $305 million, surpassing Regeneron’s prior bid. Agreement includes...
Quantum Simulations Reveal Quasicrystal Stability Mechanisms
University of Michigan researchers conducted first quantum-mechanical simulations of quasicrystals, showing that these non-repeating atomic structures can be energetically stable. Employing...
New Rapid Method Enables Vascular Organoid Construction from iPSCs
Researchers reported a novel approach to generate functional vascular organoids by simultaneous activation of endothelial and mural lineage transcription factors ETV2 and NKX3.1. This method...
Emerging Biomarkers Predict Early Parkinson’s and Support Drug Repurposing
Two studies highlight advances in Parkinson’s research: one identifies perivascular fluid diffusivity as an early clinical progression biomarker using advanced MRI, enabling prognosis prior to...
Proteomics Integration Advances Multiomics Research Landscape
The integration of proteomics with DNA sequencing technologies is accelerating multiomics approaches in biological research. Collaborations between Ultima Genomics and Olink Proteomics, as well as...
FDA Moves Signal Enabling Expanded Uses and Regulatory Changes
Notable FDA news includes approval of Moderna’s RSV vaccine expansion to at-risk younger adults and Medtronic’s clearance of a miniature defibrillation lead for pediatric use. Additionally,...
AI Accelerates Scientific Communication and Drug Discovery Insights
Innovations in artificial intelligence are reshaping scientific communication and drug discovery. AI-generated podcasts are effectively summarizing complex cardiovascular nursing research, gaining...